1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > 2016-2020 US Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Complete report $9,800.  DataPack (test volumes, sales forecasts, supplier shares) $6,400.  The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.

This new report from VPGMarketResearch.com is based on a study of the major business opportunities emerging in the US cancer diagnostics market during the next five years. The report examines trends in the US market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the US cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.

US Market Overview

- Five-year test volume and sales projections.

- Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers.

- Estimated universe of laboratories performing cancer diagnostic testing.

- Cancer statistics, etiology and recent developments in the US.

Business Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Over 200 Current and Emerging Cancer Diagnostic Test

- Oncogenes
- Biochemical Markers
- Growth Factors
- Colony Stimulating Factors
- Hormones
- Immunohistochemical Stains
- Lymphokines

Supplier Shares, Sales and Volume Forecasts

- Sales and market shares of major cancer diagnostic product suppliers by individual test.

- Five-year test volume and sales forecasts for major tumor markers by market segment, including:

     º  Hospitals
     º  Commercial/Private Laboratories
     º  Physician Offices/Group Practices
     º  Cancer Clinics
     º  Ambulatory Care Centers

Instrumentation Review

- Analysis of major molecular diagnostic and immunodiagnostic analyzers used for cancer testing, including their operating characteristics, features and selling prices.

Technology Assessment

- Assessment of latest technologies and their potential applications for cancer diagnostic testing.

- Review of competing/complementing technologies.

- Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies.

Competitive Strategies

- Strategic assessments of major suppliers and start-up firms developing innovative cancer diagnostic technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

- The companies analyzed in the report include:

   - Abbott
   - AdnaGen
   - Agilent Technologies
   - Applied Gene Technologies
   - Arca Biopharma
   - Beckman Coulter/Danaher
   - Becton Dickinson
   - Biomedical Diagnostics
   - bioMerieux
   - Bio-Rad
   - CellSearch
   - Cepheid
   - Correlogic Systems/Vermillion
   - Decode Genetics
   - Diadexus
   - Diagnocure
   - DiaSorin
   - Eiken Chemical
   - Elitech Group
   - Enterix
   - Enzo Biochem
   - Epigenomics
   - Exact Sciences
   - Fujirebio
   - Guided Therapeutics
   - Hologic/Gen-Probe
   - Kreatech/Leica
   - Kyowa Medex
   - Mackay Life Sciences
   - Myriad Genetics
   - OncoLab
   - Ortho-Clinical Diagnostics
   - Panacea Pharmaceuticals
   - Polartechnics
   - Polymedco
   - PreMD
   - Qiagen
   - Quest Diagnostics
   - Radient Pharmaceuticals
   - Roche
   - Scienion
   - Sequenom
   - Siemens Healthcare
   - Takara Bio
   - Targeted Diagnostics & Therapeutics
   - Thermo Fisher
   - Tosoh
   - Veridex
   - Wako Pure Chemicals
   - Wallac/PE
   - Zilla

Contains 620 pages and 103 tables

Table Of Contents

2016-2020 US Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
Market Segmentation Analysis of the US Cancer Diagnostics Industry:
Oncogenes, Bichemical Markers, Lymphokines, GFs, CSFs, Hormones,
Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations
Partial Table of Contents
(Contact Client Services to receive complete Table of Contents)

I. Introduction
II. Worldwide Market Overview
A. Market Overview
B. Worldwide Market Structure
C. Worldwide Market Size and Growth
III. Major Product Development Opportunities
A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
VI. Potential Market Entry Barriers and Risks
VII. Worldwide Market and Technology Overview
A. Major Current and Emerging Cancer Diagnostic Tests
1. Biochemical Tumor Markers

2. Oncogenes

3. Polypeptide Growth Factors

4. Ectopic Hormones
5. Colony Stimulating Factors
6. Lymphokines
7. Immunohistochemical Stains
8. Emerging Tumor Markers
Table of Contents
B. Instrumentation Review and Market Needs
C. Current and Emerging Technologies

D. Personal Testing
VIII. U.S.A.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Test and Market Segment
- Sales Forecasts by Test and Market Segment
- Major Supplier Sales and Market Shares
IX. Competitive Profiles
- Abbott
- AdnaGen
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Correlogic Systems/Vermillion
- Decode Genetics
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Elitech Group
- Epigenomics
- Enterix
Table of Contents
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech/Leica
- Kyowa Medex
- Mackay Life Sciences
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics and Therapeutics
- Thermo Fisher
- Tosoh
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zila

X. Appendix: Major Universities and Research
Centers Developing Cancer Diagnostic
Technologies and Applications



List of Tables

Cancer Diagnostic Classification
Major Companies Developing or Marketing
ACTH Tests
Major Companies Developing or Marketing
AFP Tests
Major Companies Developing or Marketing
Beta-2 Microglobulin Tests
Major Companies Developing or Marketing
CA 15-3/27.29 Tests
Major Companies Developing or Marketing
CA 19-9 Tests
Major Companies Developing or Marketing
CA 125 Tests
Major Companies Developing or Marketing
Calcitonin Tests
Major Companies Developing or Marketing
CEA Tests
Major Companies Developing or Marketing
Estrogen Receptor Tests
Major Companies Developing or Marketing
Progesterone Receptor Tests
Major Companies Developing or Marketing
Ferritin Tests
Major Companies Developing or Marketing
Gastrin Tests


List of Tables
Major Companies Developing or Marketing
HCG Tests

Major Companies Developing or Marketing
Insulin Tests

Major Companies Developing or Marketing
NSE Tests
Major Companies Developing or Marketing
Occult Blood Tests
Major Companies Developing or Marketing
PAP Smear/HPV Tests
Major Companies Developing or Marketing
PAP Tests
Major Companies Developing or Marketing
PSA Tests
Major Companies Developing or Marketing
Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications
In Cancer Diagnosis
Oncogenes Potential Applications
In Cancer Diagnosis
Major Companies Developing or Marketing
Oncogene Tests
Growth Factors Potential Applications
In Cancer Diagnosis
Colony Stimulating Factors Potential
Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis


List of Tables
Immunohistochemical Stains Potential
Applications in Cancer Diagnosis
Executive Summary Table: U.S., Total Cancer
Diagnostic Testing Volume and Sales Forecasts
By Market Segment
U.S., Estimated New Cancer Cases and Deaths

U.S., Estimated Cancer Death Rates
U.S., Laboratories Performing Cancer
Diagnostic Tests by Market Segment
U.S., Hospital Laboratories Performing
Cancer Diagnostic Tests by Bed Size
U.S., Commercial/Private Laboratories
Performing Cancer Diagnostic Tests
By Annual Test Volume
U.S., Physician Office Laboratories
Performing Cancer Diagnostic Tests
By Practice Size
U.S., Total Cancer Diagnostic Test Volume
Forecasts by Market Segment

U.S., All Market Segments Major
Cancer Diagnostic Test Volume Forecasts
U.S., Hospital Laboratories Major Cancer
Diagnostic Test Volume Forecasts by Test
U.S., Commercial/Private Laboratories
Major Cancer Diagnostic Test Volume Forecasts
U.S., Physician Offices/Group Practices
Major Cancer Diagnostic Test Volume Forecasts


List of Tables
U.S., Cancer Clinics Major Cancer
Diagnostic Test Volume Forecasts by Test
U.S., Total Cancer Diagnostic Sales
Forecasts by Market Segment
U.S., All Market Segment Major Cancer
Diagnostic Sales Forecasts by Test
U.S., Hospital Laboratories Major Cancer
Diagnostic Sales Forecasts by Test
U.S., Commercial/Private Laboratories
Major Cancer Diagnostic Sales Forecasts by Test
U.S., Physician Offices/Group Practices
Major Cancer Diagnostic Sales Forecasts by Test
U.S., Cancer Clinics Major Tumor
Marker Sales Forecasts by Test
U.S., ACTH Test Volume and Diagnostics
Sales Forecasts by Market Segment

U.S., AFP Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.S., Beta-2 Microglobulin Test Volume and
Diagnostics Sales Forecasts by Market Segment
U.S., CA 15-3/27.29 Test Volume and
Diagnostics Sales Forecasts by Market Segment
U.S., CA 19-9 Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.S., CA-125 Test Volume and Diagnostics
Sales Forecasts by Market Segment


List of Tables
U.S., Calcitonin Test Volume and
Diagnostics Sales Forecasts by Market Segment
U.S., Cathepsin Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.S., CEA Test Volume and Diagnostics
Sales by Market Segment
U.S., Chromogranin Test Volume and
Diagnostics Sales Forecasts by Market Segment
U.S., Colon-specific Antigen Test Volume
And Diagnostics Sales Forecasts by Market Segment
U.S., Cytokeratins Test Volume
And Diagnostics Sales Forecasts by Market Segment
U.S., Estrogen Receptor Test Volume
And Diagnostics Sales Forecasts by Market Segment

U.S., Ferritin Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.S., Gastrin Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.S., HCG Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.S., Insulin Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.S., Interferons Test Volume
And Diagnostics Sales Forecasts
by Market Segment
U.S., Interleukins Test Volume
And Diagnostics Sales Forecasts
by Market Segment


List of Tables
U.S., Lymphocyte Subtyping Test Volume and
Diagnostics Sales Forecasts by Market Segment
U.S., NSE Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.S., Nucleolar Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.S., Occult Blood Test Volume
And Diagnostics Sales Forecasts by Market Segment
U.S., Oncogenes Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.S., Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.S., PAP Smear Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.S., Parathyroid Hormone
Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.S., Progesterone Receptor
Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.S., PAP Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.S., PSA Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.S., S-100 Protein Test Volume and
Diagnostics Sales Forecasts by Market
Segment


List of Tables
U.S., Serotonin Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.S., Sialic Acid Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.S., Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.S., TDT Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.S., Thymidine Kinase
Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.S., Thyroglobulin Test
Volume and Diagnostics
Sales Forecasts by Market Segment
U.S., TPA Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.S., Total Cancer Diagnostics Sales
By Major Supplier
U.S., ACTH Testing Market Diagnostics
Sales by Major Supplier
U.S., AFP Testing Market Diagnostics
Sales by Major Supplier
U.S., Beta-2 Migroblolulin Testing Market Diagnostics Sales
By Major Supplier
U.S., CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
U.S., CA 19-9 Testing Market Diagnostics
Sales by Major Supplier


List of Tables
U.S., CA 125 Testing Market Diagnostics
Sales by Major Supplier
U.S., CEA Testing Market Diagnostics
Sales by Major Supplier
U.S., Ferritin Testing Market
Diagnostics Sales by Major Supplier
U.S., HCG Testing Market
Diagnostics Sales by Major Supplier
U.S., Insulin Testing Market
Diagnostics Sales by Major Supplier
U.S., Parathyroid Hormone Testing Market
Diagnostics Sales by Major Supplier
U.S., PAP Testing Market Diagnostics
Sales by Major Supplier
U.S., Progesterone Receptor Testing Market
Diagnostics Sales by Major Supplier
U.S., PSA Testing Market Diagnostics
Sales by Major Supplier

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and ...

Europe Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800.VPGMarketResearch.com's new report is a strategic analysis of the major business opportunities emerging in the ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.